Targeted Cancer Therapy Connect is a peer-reviewed, open-access journal dedicated to advancing precision and targeted approaches in cancer treatment. The journal publishes innovative research that deepens understanding of the molecular and immunological mechanisms driving cancer progression and therapeutic response. This open-access journal follows a continuous publication model and is licensed under Creative Commons Attribution 4.0 (CC BY 4.0).
Submission Deadline: 31 Jan 2026 Published Articles: 0